Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00482_DB01045_nanopub.RAWKvU69NwXsl0JEL17wah7AD0VszZUq_gaWIoV0WtKF4#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00482_DB01045 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00482_DB01045 label "DDI between Celecoxib and Rifampicin - Rifampin, a strong CYP2C9 inducer, may decrease the serum levels of celecoxib by increasing its metabolism. Monitor for changes in the therapeutic and adverse effects if rifampin is initiated, discontinued or dose changed. [drugbank_resource:DB00482_DB01045]" assertion.
- drugbank_resource:DB00482_DB01045 identifier "drugbank_resource:DB00482_DB01045" assertion.
- drugbank_resource:DB00482_DB01045 title "DDI between Celecoxib and Rifampicin - Rifampin, a strong CYP2C9 inducer, may decrease the serum levels of celecoxib by increasing its metabolism. Monitor for changes in the therapeutic and adverse effects if rifampin is initiated, discontinued or dose changed." assertion.
- drugbank:DB01045 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00482_DB01045 assertion.
- drugbank:DB00482 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00482_DB01045 assertion.